Disease | carcinoma, squamous cell |
Comorbidity | C0079474|recessive dystrophic epidermolysis bullosa |
Sentences | 5 |
PubMedID- 20586780 | Background: tumour-specific expression of matrix metalloproteinase (mmp)-7 has been noted in cutaneous squamous cell carcinomas (sccs) in patients with recessive dystrophic epidermolysis bullosa (rdeb). |
PubMedID- 25758658 | Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases. |
PubMedID- 22564523 | Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. |
PubMedID- 23398414 | Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. |
PubMedID- 23926398 | A male patient with humoral hypercalcemia of malignancy (hhm) with leukocytosis caused by cutaneous squamous cell carcinoma resulting from recessive dystrophic epidermolysis bullosa. |
Page: 1